Shanxi Zhendong Pharmaceutical (300158) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million ≈ $-28.96 Million USD) by net assets (CN¥3.63 Billion ≈ $530.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanxi Zhendong Pharmaceutical (300158) liquidity interval to measure how many days the company can operate on defensive assets alone.

Shanxi Zhendong Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Time Publishing and Media Co Ltd Class A SHG:600551	-0.006x
India Glycols Limited NSE:INDIAGLYCO	0.036x
Link Mobility Group Holding ASA OL:LINK	0.122x
Chongqing Constr Engineering SHG:600939	-0.013x
Dakota Gold Corp. NYSE MKT:DC	-0.063x
Quanta Storage TWO:6188	-0.024x
Fujian Zhangzhou Development Co Ltd SHE:000753	0.034x
Laan & Spar Bank AS CO:LASP	-0.418x

Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300158 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.66 Billion ≈ $535.61 Million	CN¥-149.82 Million ≈ $-21.92 Million	-0.041x	-10.85%
2023-12-31	CN¥5.14 Billion ≈ $752.74 Million	CN¥-189.95 Million ≈ $-27.80 Million	-0.037x	-323.47%
2022-12-31	CN¥5.22 Billion ≈ $764.33 Million	CN¥86.31 Million ≈ $12.63 Million	0.017x	-53.21%
2021-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥284.45 Million ≈ $41.62 Million	0.035x	-10.36%
2020-12-31	CN¥5.63 Billion ≈ $824.31 Million	CN¥221.94 Million ≈ $32.48 Million	0.039x	+15.04%
2019-12-31	CN¥5.44 Billion ≈ $796.21 Million	CN¥186.35 Million ≈ $27.27 Million	0.034x	+18.89%
2018-12-31	CN¥5.36 Billion ≈ $784.69 Million	CN¥154.48 Million ≈ $22.60 Million	0.029x	+255.11%
2017-12-31	CN¥5.56 Billion ≈ $813.28 Million	CN¥45.09 Million ≈ $6.60 Million	0.008x	+195.63%
2016-12-31	CN¥5.27 Billion ≈ $771.41 Million	CN¥-44.72 Million ≈ $-6.54 Million	-0.008x	-111.34%
2015-12-31	CN¥2.03 Billion ≈ $297.12 Million	CN¥151.84 Million ≈ $22.22 Million	0.075x	+101.19%
2014-12-31	CN¥1.97 Billion ≈ $288.29 Million	CN¥73.23 Million ≈ $10.72 Million	0.037x	+197.00%
2013-12-31	CN¥1.96 Billion ≈ $286.56 Million	CN¥-75.04 Million ≈ $-10.98 Million	-0.038x	-138.43%
2012-12-31	CN¥1.90 Billion ≈ $277.96 Million	CN¥189.40 Million ≈ $27.72 Million	0.100x	+308.83%
2011-12-31	CN¥1.86 Billion ≈ $271.95 Million	CN¥-88.73 Million ≈ $-12.98 Million	-0.048x	-362.53%
2010-12-31	CN¥1.78 Billion ≈ $260.67 Million	CN¥32.40 Million ≈ $4.74 Million	0.018x	-84.54%
2009-12-31	CN¥359.31 Million ≈ $52.58 Million	CN¥42.28 Million ≈ $6.19 Million	0.118x	-5.43%
2008-12-31	CN¥266.72 Million ≈ $39.03 Million	CN¥33.18 Million ≈ $4.86 Million	0.124x	-82.94%
2007-12-31	CN¥176.42 Million ≈ $25.82 Million	CN¥128.65 Million ≈ $18.82 Million	0.729x	--

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic

Market Cap

$698.44 Million

CN¥4.77 Billion CNY

Market Cap Rank

#10736 Global

#2987 in China

Share Price

CN¥4.81

Change (1 day)

+0.42%

52-Week Range

CN¥4.32 - CN¥9.45

All Time High

CN¥12.00